Celsus Therapeutics Closes $12.5 Million Private Placement  
10/1/2013 9:27:19 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK and LONDON, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Celsus Therapeutics (OTCQB:CLSXY), an emerging growth, development-stage biopharmaceutical company, announced today that it has closed a previously announced securities purchase agreement for a private placement financing with a select group of institutional healthcare investors. With the closing of the transaction, Celsus will receive gross proceeds of approximately $12.5 million from the sale of 21,958,302 ordinary shares at a price of $0.57 per share.

Help employers find you! Check out all the jobs and post your resume.